| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3992926 | Journal of Thoracic Oncology | 2006 | 7 Pages |
Abstract
Combining 74-Gy thoracic radiation and concurrent gemcitabine is feasible, but the use of this regimen should be limited to the confines of a clinical trial. A randomized phase II trial through the Cancer and Leukemia Group B is underway to further evaluate the efficacy of this regimen.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A William MD, Coty MD, Jerome MD, June BA, L Douglas PhD, William PhD, Antonius A. MD,